Number of the records: 1  

Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors

  1. TitleChromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors
    Author Timmerman Dennis M.
    Co-authors Eleveld Thomas F.

    Sriram Sruthi

    Dorssers Lambert C. J.

    Gillis Ad J. M.

    Schmidtová Silvia SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV    RID    ORCID

    Kaľavská Katarína 1987- SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV

    Werken, van de Harmen J.G.

    Oing Christoph

    Honecker Friedemann

    Mego Michal SAVBIOMED ; SAVEXONK - Biomedicínske centrum SAV

    Looijenga Leendert H.J.

    Source document Journal of Clinical Oncology. Vol. 40, no. 26(2022), p. 3077-3087
    Languageeng - English
    CountryUS - United States of America
    Noteopen access
    URLURL link
    Document kindrozpis článkov z periodík (rbx)
    CitationsTAKAMI, H. - ICHIMURA, K. Biomarkers for risk-based treatment modifications for CNS germ cell tumors: Updates on biological underpinnings, clinical trials, and future directions. In FRONTIERS IN ONCOLOGY. ISSN 2234-943X, SEP 5 2022, vol. 12. Dostupné na: https://doi.org/10.3389/fonc.2022.982608.
    CategoryADCA - Scientific papers in foreign journals registered in Current Contents Connect with IF (impacted)
    Category of document (from 2022)V3 - Vedecký výstup publikačnej činnosti z časopisu
    Type of documentčlánok
    Year2022
    Registered inWOS
    Registered inSCOPUS
    Registered inCCC
    DOI 10.1200/JCO.21.02809
    article

    article

    File nameAccessSizeDownloadedTypeLicense
    Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent.pdfavailable521.9 KB2Publisher's version
    rokCCIFIF Q (best)JCR Av Jour IF PercSJRSJR Q (best)CiteScore
    A
    rok vydaniarok metrikyIFIF Q (best)SJRSJR Q (best)
    2022202150.739Q19.378Q1
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.